Hyperion DeFi, Inc. (NASDAQ:HYPD) Given Consensus Rating of “Hold” by Analysts

Hyperion DeFi, Inc. (NASDAQ:HYPD) has been given an average recommendation of “Hold” by the five analysts that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $4.5833.

A number of research firms have recently weighed in on HYPD. Chardan Capital set a $7.75 price target on shares of Hyperion DeFi and gave the stock a “buy” rating in a research note on Wednesday, December 24th. Wall Street Zen raised Hyperion DeFi from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperion DeFi in a report on Wednesday, October 8th. Zacks Research upgraded Hyperion DeFi to a “hold” rating in a report on Monday, December 29th. Finally, Cantor Fitzgerald assumed coverage on shares of Hyperion DeFi in a research note on Tuesday, December 16th. They issued an “overweight” rating and a $4.00 target price for the company.

Hyperion DeFi Price Performance

NASDAQ HYPD opened at $3.85 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.25 and a quick ratio of 2.25. The firm has a market capitalization of $31.45 million, a price-to-earnings ratio of -0.95 and a beta of 2.69. The company has a 50 day simple moving average of $4.37 and a 200-day simple moving average of $7.57. Hyperion DeFi has a 52-week low of $0.85 and a 52-week high of $17.18.

Hyperion DeFi (NASDAQ:HYPD) last released its quarterly earnings data on Friday, November 14th. The company reported $0.05 earnings per share for the quarter. The company had revenue of $0.36 million during the quarter. Equities research analysts predict that Hyperion DeFi will post -41.6 earnings per share for the current fiscal year.

Insider Buying and Selling at Hyperion DeFi

In other Hyperion DeFi news, Director Ellen R. Strahlman acquired 11,856 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The stock was purchased at an average cost of $3.61 per share, for a total transaction of $42,800.16. Following the completion of the acquisition, the director owned 34,869 shares of the company’s stock, valued at approximately $125,877.09. This trade represents a 51.52% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO David R. Knox bought 27,950 shares of the stock in a transaction on Wednesday, December 31st. The shares were acquired at an average cost of $3.59 per share, for a total transaction of $100,340.50. Following the completion of the transaction, the chief financial officer directly owned 327,950 shares of the company’s stock, valued at approximately $1,177,340.50. The trade was a 9.32% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 189,204 shares of company stock worth $611,467 in the last 90 days. 10.86% of the stock is currently owned by company insiders.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.